Stryker has appointed Mike Carlin to lead its digital and robotics business. Spencer Stiles, Stryker’s group president of ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker’s Incompass Total Ankle System, designed ...

Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe ...

There has been a shift in leadership for the Digital, Robotics and Enabling Technologies business at Stryker (NYSE: SYK) + ...

Stryker (NYSE:SYK) announced today that it received FDA 510(k) clearance for its Incompass total ankle system.

This was the stock's fourth consecutive day of gains.

Stryker has secured FDA clearance for its Incompass total ankle system to treat patients whose ankle joints have been damaged by severe rheumatoid, post-traumatic or degenerative arthritis. The ...

Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.